Distance between leadership and direct care creates disconnect for patients

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

Marten den Haring, CEO of Lirio, says the company uses its Large Behavior Model, which blends behavioral science with artificial intelligence, with the goal of driving consumer engagement in healthcare at the personal level.

Jackie Mattingly of Clearwater advises small- to medium-sized hospitals to improve accountability and streamline technical complexities now to improve their cybersecurity postures in this look at what rural providers face.